Embecta Corp (EMBC)
13.82
-0.18
(-1.29%)
USD |
NASDAQ |
Nov 22, 16:00
13.86
+0.04
(+0.33%)
After-Hours: 20:00
Embecta Enterprise Value: 2.123B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 2.123B |
| November 21, 2024 | 2.133B |
| November 20, 2024 | 2.111B |
| November 19, 2024 | 2.103B |
| November 18, 2024 | 2.157B |
| November 15, 2024 | 2.169B |
| November 14, 2024 | 2.194B |
| November 13, 2024 | 2.214B |
| November 12, 2024 | 2.224B |
| November 11, 2024 | 2.235B |
| November 08, 2024 | 2.222B |
| November 07, 2024 | 2.207B |
| November 06, 2024 | 2.267B |
| November 05, 2024 | 2.189B |
| November 04, 2024 | 2.164B |
| November 01, 2024 | 2.147B |
| October 31, 2024 | 2.138B |
| October 30, 2024 | 2.152B |
| October 29, 2024 | 2.160B |
| October 28, 2024 | 2.141B |
| October 25, 2024 | 2.127B |
| October 24, 2024 | 2.136B |
| October 23, 2024 | 2.134B |
| October 22, 2024 | 2.143B |
| October 21, 2024 | 2.135B |
| Date | Value |
|---|---|
| October 18, 2024 | 2.112B |
| October 17, 2024 | 2.107B |
| October 16, 2024 | 2.116B |
| October 15, 2024 | 2.106B |
| October 14, 2024 | 2.081B |
| October 11, 2024 | 2.065B |
| October 10, 2024 | 2.045B |
| October 09, 2024 | 2.078B |
| October 08, 2024 | 2.113B |
| October 07, 2024 | 2.089B |
| October 04, 2024 | 2.105B |
| October 03, 2024 | 2.092B |
| October 02, 2024 | 2.130B |
| October 01, 2024 | 2.139B |
| September 30, 2024 | 2.139B |
| September 27, 2024 | 2.142B |
| September 26, 2024 | 2.164B |
| September 25, 2024 | 2.163B |
| September 24, 2024 | 2.195B |
| September 23, 2024 | 2.204B |
| September 20, 2024 | 2.226B |
| September 19, 2024 | 2.232B |
| September 18, 2024 | 2.220B |
| September 17, 2024 | 2.277B |
| September 16, 2024 | 2.276B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.886B
Minimum
Apr 30 2024
3.306B
Maximum
Dec 13 2022
2.539B
Average
2.458B
Median
Jul 21 2023
Enterprise Value Benchmarks
| Boston Scientific Corp | 141.27B |
| Abbott Laboratories | 211.67B |
| Nevro Corp | 114.60M |
| iRhythm Technologies Inc | 2.440B |
| Inari Medical Inc | 2.796B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 14.70M |
| Revenue (Quarterly) | 272.50M |
| Total Expenses (Quarterly) | 216.60M |
| EPS Diluted (Quarterly) | 0.25 |
| Gross Profit Margin (Quarterly) | 69.76% |
| Profit Margin (Quarterly) | 5.39% |
| Earnings Yield | 8.68% |
| Operating Earnings Yield | 21.15% |
| Normalized Earnings Yield | 8.683 |